HRT and its impact on the menopause, osteoporosis and breast cancer

Bibliography

• GRADY D, RUBIN SM, PETITTI DB, FOX CS: Hormonetherapy to prevent disease and prolong life in postmenopausal women. Ann. Intern. Med. (1992) 117:1016–1037.
   PubMed Web of Science ®Google Scholar
• BARRETT-CONNOR E: Hormone replacement therapy.Br. Med. J. (1998) 317:457–461.
   PubMed Web of Science ®Google Scholar
• HULLEY S, GRADY D, BUSH T et al: Randomised trial of estrogen and progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA (1998) 280:605–613.
   PubMed Web of Science ®Google Scholar
• MULNARD RA, COTMAN CW, KAWAS C et al: Estrogen replacement therapy for treatment of mild to moderate alzheimer's disease: a randomized controlled trial. JAMA (2000) 283:1007–1015.
   PubMed Web of Science ®Google Scholar
• WIKLUND I, KARLBERG J, MATTSSON L: Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study. Am. J Obstet. (1993) 168:824–830.
   PubMed Web of Science ®Google Scholar
• TORGERSON DJ: The economics of bone density screeningand the subsequent use of hormone replace-ment therapy. PhD Thesis. (1996).
   Google Scholar
• PEARCE J, HAWTON K, BLAKE F: Psychological and sexual symptoms associated with the menopause and the effects of hormone replacement therapy. Br. J Psych. (1995) 167:163–173.
   PubMed Web of Science ®Google Scholar
• ZWEIFEL JE, O'BRIEN WH: A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology (1997) 22:189–212.
   PubMedGoogle Scholar
• COOPE J, THOMSON JM, POLLER L. Effect of 'natural oestrogen' replacement therapy on menopausal symptoms and blood clotting. Br. Med. J (1975) 4:139–143.
   Google Scholar
• CAMPBELL S: Double-blind psychometric studies on the effects of natural estrogens on postmenopausal women. MTP Press, Lancaster, UK (1976).
   Google Scholar
• FEDOR-FREYBERGH P: The influence of oestrogens on the wellbeing and mental performance of climacteric and postmenopausal women. Acta Obstetricia et Gyneco-logica Scandinavia (1977) (Suppl. 64).
   Google Scholar
• THOMSON J, OSWALD I: Effect of oestrogen on the sleep, mood and anxiety of menopausal women. Br. Med. J. (1977) 2:1317–1319.
   PubMed Web of Science ®Google Scholar
• BAU MGARDNER SB, CONDREA H, DANNE TA et al: Replacement estrogen therapy for menopausal vasomotor flushes. Obstet. Gynecol. (1978) 51:445–452.
   PubMedGoogle Scholar
• DENNERSTEIN L, BURROWS GD, WOOD C, HYMAN G: Hormones and sexuality: effect of estrogen and progestogen. Obstet. Gynecol. (1980) 56:316–322.
   PubMed Web of Science ®Google Scholar
• COPPEN A, BISHOP M, BEARD RJ, BARNARD GJR, COLLINS WP: Hysterectomy, hormones and behaviour. Lancet (1981) 1:126–28.
   PubMed Web of Science ®Google Scholar
• JENSEN JCC: Dose-response and withdrawal effects on climacteric symptoms after hormonal replacement therapy. A placebo-controlled therapeutic trial. Maturitas (1983) 5:125–133.
   Google Scholar
• BRINCAT M, STUDD JWW, O'DOWD T, MAGOS A, CARDOZO LD, WARDLE PJ: Subcutaneous hormone implants for the control of climacteric symptoms. Lancet (1984):16–18.
   PubMedGoogle Scholar
• STEINGOLD KA, LAUFER L, CHETKOWSKI RJ et al: Treatment of hot flashes with transdermal estradiol administration. J. Clin. Endocrinol Metab. (1985) 61:627–632.
   PubMed Web of Science ®Google Scholar
• DITKOFF EC, CRARY WG, CRISTO M, LOBO RA: Estrogenimproves psychological function in asymptomatic postmenopausal women. Obstet. Gynecol (1991) 78:991–995.
   PubMed Web of Science ®Google Scholar
• MARSLEW U, RIIS B, CHRISTANSEN C: Progestogens: therapeutic and adverse effects in early and postmeno-pausal women. Maturitas (1991) 13:7–16.
   PubMed Web of Science ®Google Scholar
• MARSLEW U, RIIS B, CHRISTANSEN C: Desogestrel in hormone replacement therapy: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms and bleed. Eur. J. Clin. Invest. (1991) 21:601–607.
   PubMed Web of Science ®Google Scholar
• MARSLEW U, OVERGAARD K, RIIS BJ, CHRISTANSEN C:Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabo-lism, climacteric symptoms and bleeding. Obstet. Gynecol. (1992) 79:202–210.
   PubMed Web of Science ®Google Scholar
• WIKLUND I, BERG G, HAMMAR M, KARLBERG J, LINDGREN R, SANDIN K: Long-term effect of transdermal hormonal therapy on aspects of quality of life in postmenopausal women. Maturitas (1992) 14:225–236.
   PubMed Web of Science ®Google Scholar
• OBEL EB, MUNK-JENSEN N, SVENSTRUP B et al: A two year double-blind controlled study of the clinical effect of combined and sequential postmenopausal replacement therapy and steroid metabolism during treatment. Maturitas (1993) 16:13–21.
   PubMed Web of Science ®Google Scholar
• GORDON SF, THOMPSON KA, RUOFF GE, IMIG JR, LANE PJ, SCHVVENKER CE: Efficacy and safety of a seven-day transdermal estradiol drug-delivery system: comparison with conjugated estrogens and placebo. Int. J. Fertility (1995) 40:126–134.
   Google Scholar
• DALY E RM, BARLOW D, GRAY A, MCPHERSON K, VESSEY M: HRT: An analysis of benefits, risks and costs. Br. Med. Bull. (1992) 48(2):368–400.
   PubMedGoogle Scholar
• ZETHRAEUS N: Willingness to pay for hormonereplacement therapy. Health Economics (1998) 7:31–38.
   PubMed Web of Science ®Google Scholar
• MEDICAL RESEARCH COUNCIL: Randomised comparison of oestrogen versus oestrogen plus progestogen hormone replacement therapy in women with hysterectomy. Br. Med. J. (1996) 312:473–478.
   PubMedGoogle Scholar
• THE WRITING GROUP FOR THE PEPI TRIAL: Effect ofhormone therapy on bone mineral density. JAMA (1996) 276:1389–1396.
   PubMed Web of Science ®Google Scholar
• RECKER RR, DAVIES KM, RM D, HEANEY RP: The effect oflow-dose continuous estrogen and progesterone therapy with calcium and vitamin don bone in elderly women: a randomized controlled trial. Ann. Intern. Med. (1999) 130:897–904.
   PubMed Web of Science ®Google Scholar
• CHAPUY MC, ARLOTT ME, DUBOEUFF F et al.: Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl. J. Med. (1992) 327:1637–1642.
   PubMed Web of Science ®Google Scholar
• LIPS P, WILCO C, GRAAFMANS MS, 00MS ME, BEZEMER PD, BOUTER LM: Vitamin D supplementation and fracture incidence in elderly persons: A randomized controlled trial. Ann. Intern. Med. (1996) 124:400–406.
   PubMed Web of Science ®Google Scholar
• MICHAELSSON K, BARON JA, FARAHMAND BY et al: Hormone replacement therapy and the risk of hip fracture: population based case-control. Br. Med. J (1998) 316:1858–1863.
   PubMed Web of Science ®Google Scholar
• WEISS NS, CAROL PH, URE L, BALLARD JH, WILLIAMS AR, DARLING JR: Decreased risk of fractures of the hip and lower forearm with postmenopausal use of oestrogen. N Engl. J Med. (1980) 303:1195–1198.
   PubMed Web of Science ®Google Scholar
• ETTINGER B, GENANT HK, CANN CE: Long-term estrogen replacement therapy prevents bone loss and fractures. Ann. Intern. Med. (1985) 102:319–324.
   PubMed Web of Science ®Google Scholar
• HUTCHINSON TA, POLANSKY SM, FEINSTEIN AR: Postmenopausal oestrogens protect against fractures of hip and distal radius: a case-control study. Lancet (1979) 2:705–709.
   PubMed Web of Science ®Google Scholar
• WILLIAMS AR, WEISS NS, URE CL, BALLARD J, DALING JR: Effect of weight, smoking and estrogen use on the risk of hip and forearm fractures in postmenopausal women. Obstet. Gynecol. (1982) 60:695–699.
   PubMed Web of Science ®Google Scholar
• KIEL DP, FELSON DT, ANDERSON JJ, WILSON PWF, MAM: Hip fracture and the use of estrogens in postmeno-pausal women. N Engl. J. Med. (1987) 317:1169–1174.
   PubMed Web of Science ®Google Scholar
• SPECTOR TD, BRENNAN P, HARRIS PA, STUDD JWW, AJS: Do current regimes of hormone replacement therapy protect against subsequent fractures? Osteoporosis International (1992) 2:219–224.
   PubMedGoogle Scholar
• NAESSEN T, PERSSON I, ADAMI HO, BERGSTROM R, BERGKVIST L: Hormone replacement therapy and the risk of first hip fracture. Ann. Intern. Med. (1990) 113:95–103.
   PubMed Web of Science ®Google Scholar
• KANIS J, JOHNELL 0, GULLBERG B: Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture. Br. Med. J. (1992) 305:1124–1128.
   PubMed Web of Science ®Google Scholar
• CAULEY JA, SEELEY DG, ENSRUD K, ETTINGER B, BLACK D, CUMMINGS SR: Estrogen replacement therapy and fractures in older women. Ann. Intern. Med. (1995) 122:9–16.
   PubMed Web of Science ®Google Scholar
• HONKANEN RJ, HONKANEN K, KROGER H, ALHAVA E,TUPPERAINEN M, SAARIKOSKI S: Risk factors for perimenopausal distal forearm fracture. Osteoporosis International (2000) 11:265–270.
   PubMed Web of Science ®Google Scholar
• OTT SM: Estrogen therapy for osteoporosis - even in the elderly. Ann. Intern. Med. (1992) 117:85–86.
   PubMedGoogle Scholar
• ETTINGER B, BLACK DM, MITLAK BH et al.: Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. JAMA (1999) 282:637–645.
   PubMed Web of Science ®Google Scholar
• KOMULAINEN MH, KROGER H, TUPPURAINEN MT et al.: HRTand Vit Din prevention of non-vertebral fractures in postmenopausal women: a 5 year randomised trial. Maturitas (1998) 31:45–54.
   PubMed Web of Science ®Google Scholar
• LUFKIN EG, WAHNER HW, O'FALLON WM et al.: Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann. Intern. Med. (1992) 117:1–9.
   Google Scholar
• WINDELER J, LANGE S: Events per person year - a dubious concept. Br. Med. J. (1995) 310:454–456.
   PubMed Web of Science ®Google Scholar
• COLLABORATIVE GROUP ON HORMONAL FACTORS INBREAST CANCER: Breast cancer and hormone replace-ment therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108 411 without breast cancer. Lancet (1997) 350:1047–1059.
   PubMedGoogle Scholar
• CAULEY JA, LUCAS FL, KULLER LH, VOGT MT, BROWNERWS, CUMMINGS SR: Bone mineral density and risk of breast cancer in older women. j Am. Med. Assoc. (1996) 17:1404–1408.
   Google Scholar
• ZHANG Y, KIEL DP, KREGER BE etal.: Bone mass and therisk of breast cancer among postmenopausal women. N Engl. J. Med. (1997) 336:611–617.
   Google Scholar
• HEMMINKI E, MCPHERSON K: Impact of postmeno-p ausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials. Br. Med. J (1997) 315:149–153.
   PubMed Web of Science ®Google Scholar